EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advances and Challenges in Model‐Informed Precision Dosing of Antimicrobials for Pediatric Patients

Jing Kai Lam, Xiaoyan Yang, Baharudin Ibrahim, Amirrudin Kamsin, Jinxin Zhao, S. Y. Amy Cheung, Xiaofen Liu, Jamaludin Elis, Nusaibah Abdul Rahim, Yu-Wei Lin

Journal of Clinical Pharmacy and Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/jcpt/7870942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 22.07.2026. Verfasst von Jing Kai Lam und 9 weiteren Autor:innen. Die Arbeit nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, Malaysia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision medicine has transformed healthcare by moving toward individualized treatment strategies, yet dosing optimization for pediatric patients remains a complex challenge. Therapeutic drug monitoring (TDM), a widely used practice in clinical settings, provides a foundation for achieving therapeutic goals but poses significant limitations, particularly in the pediatric population, due to the frequent need for blood sampling and delayed adjustments. Model‐informed precision dosing (MIPD) is an emerging strategy that combines population pharmacokinetic (pop‐PK) models with patient‐specific data to enhance therapeutic outcomes while minimizing the need for invasive procedures. This narrative review highlights the potential of MIPD in pediatric antimicrobial therapy, with an emphasis on its applications, advantages, and current challenges. By analyzing recent advancements in pop‐PK models for antimicrobials, this review article underscores MIPD’s ability to optimize dosing strategies and improve clinical outcomes for pediatric patients. Despite the barriers to widespread implementation, such as data availability and regulatory hurdles, MIPD offers a path forward for precision medicine in pediatrics. By bridging the gap between computational modeling and clinical practice, MIPD has the potential to reshape the future of pediatric pharmacotherapy.

Förderung

  • Ministry of Higher Education, Malaysia

Zitieren

APA

Lam, J. K., Yang, X., Ibrahim, B., Kamsin, A., Zhao, J., Cheung, S. Y. A., Liu, X., Elis, J., Rahim, N. A., & Lin, Y. (2026). Advances and Challenges in Model‐Informed Precision Dosing of Antimicrobials for Pediatric Patients. Journal of Clinical Pharmacy and Therapeutics, 2026(1). https://doi.org/10.1155/jcpt/7870942

Vancouver

Lam JK, Yang X, Ibrahim B, Kamsin A, Zhao J, Cheung SYA, et al. Advances and Challenges in Model‐Informed Precision Dosing of Antimicrobials for Pediatric Patients. Journal of Clinical Pharmacy and Therapeutics. 2026;2026(1). doi:10.1155/jcpt/7870942

BibTeX
@article{Lam2026,
  author = {Lam, Jing Kai and Yang, Xiaoyan and Ibrahim, Baharudin and Kamsin, Amirrudin and Zhao, Jinxin and Cheung, S. Y. Amy and Liu, Xiaofen and Elis, Jamaludin and Rahim, Nusaibah Abdul and Lin, Yu-Wei},
  title = {Advances and Challenges in Model‐Informed Precision Dosing of Antimicrobials for Pediatric Patients},
  journal = {Journal of Clinical Pharmacy and Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jcpt/7870942}
}
Kostenlos starten →